Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/158016 |
Resumo: | OBJECTIVES: This study aimed to provide evidence for understanding how to treat osteoarthritis (OA) in our country. Therefore, it was necessary to match information and investigations related to the treatment of the disease from the three main types of specialists involved: physiatrists, orthopedists and rheumatologists. METHODS: The authors acted as a scientific advisory committee. From the initial discussions, a structured questionnaire was developed for use with a group of specialists on OA using the Delphi technique. The questionnaire was sent to 21 experts appointed by the authors, and the results obtained were critically analyzed and validated. RESULTS: The prevalence of OA was 33% in Brazil, corresponding to one-third of the individuals in the reference population, which included individuals over 25 years of age. Another significant finding was that most patients did not receive any form of treatment in the early stages of OA. CONCLUSION: The committee pointed to the need for early intervention and that the available medicinal resources can fulfil this important role, as is the case with SYSADOA treatments. Glucosamine-based medicinal products with or without chondroitin could also fulfill this need for early treatment. The other generated evidence and included investigations were then grouped together and are the subject of this publication. |
id |
USP-19_a7cccd80e271a231f27617dadcd059ab |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/158016 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodologyOsteoarthritisOsteoarthrosisSurgical TreatmentDrug TherapyGlucosamineChondroitinOBJECTIVES: This study aimed to provide evidence for understanding how to treat osteoarthritis (OA) in our country. Therefore, it was necessary to match information and investigations related to the treatment of the disease from the three main types of specialists involved: physiatrists, orthopedists and rheumatologists. METHODS: The authors acted as a scientific advisory committee. From the initial discussions, a structured questionnaire was developed for use with a group of specialists on OA using the Delphi technique. The questionnaire was sent to 21 experts appointed by the authors, and the results obtained were critically analyzed and validated. RESULTS: The prevalence of OA was 33% in Brazil, corresponding to one-third of the individuals in the reference population, which included individuals over 25 years of age. Another significant finding was that most patients did not receive any form of treatment in the early stages of OA. CONCLUSION: The committee pointed to the need for early intervention and that the available medicinal resources can fulfil this important role, as is the case with SYSADOA treatments. Glucosamine-based medicinal products with or without chondroitin could also fulfill this need for early treatment. The other generated evidence and included investigations were then grouped together and are the subject of this publication.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-05-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/15801610.6061/clinics/2019/e722Clinics; Vol. 74 (2019); e722Clinics; v. 74 (2019); e722Clinics; Vol. 74 (2019); e7221980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/158016/153260https://www.revistas.usp.br/clinics/article/view/158016/153564Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessCoimbra, Ibsen BelliniPlapler, Pérola GrinbergCampos, Gustavo Constantino de2019-05-24T13:16:00Zoai:revistas.usp.br:article/158016Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-24T13:16Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology |
title |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology |
spellingShingle |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology Coimbra, Ibsen Bellini Osteoarthritis Osteoarthrosis Surgical Treatment Drug Therapy Glucosamine Chondroitin |
title_short |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology |
title_full |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology |
title_fullStr |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology |
title_full_unstemmed |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology |
title_sort |
Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology |
author |
Coimbra, Ibsen Bellini |
author_facet |
Coimbra, Ibsen Bellini Plapler, Pérola Grinberg Campos, Gustavo Constantino de |
author_role |
author |
author2 |
Plapler, Pérola Grinberg Campos, Gustavo Constantino de |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Coimbra, Ibsen Bellini Plapler, Pérola Grinberg Campos, Gustavo Constantino de |
dc.subject.por.fl_str_mv |
Osteoarthritis Osteoarthrosis Surgical Treatment Drug Therapy Glucosamine Chondroitin |
topic |
Osteoarthritis Osteoarthrosis Surgical Treatment Drug Therapy Glucosamine Chondroitin |
description |
OBJECTIVES: This study aimed to provide evidence for understanding how to treat osteoarthritis (OA) in our country. Therefore, it was necessary to match information and investigations related to the treatment of the disease from the three main types of specialists involved: physiatrists, orthopedists and rheumatologists. METHODS: The authors acted as a scientific advisory committee. From the initial discussions, a structured questionnaire was developed for use with a group of specialists on OA using the Delphi technique. The questionnaire was sent to 21 experts appointed by the authors, and the results obtained were critically analyzed and validated. RESULTS: The prevalence of OA was 33% in Brazil, corresponding to one-third of the individuals in the reference population, which included individuals over 25 years of age. Another significant finding was that most patients did not receive any form of treatment in the early stages of OA. CONCLUSION: The committee pointed to the need for early intervention and that the available medicinal resources can fulfil this important role, as is the case with SYSADOA treatments. Glucosamine-based medicinal products with or without chondroitin could also fulfill this need for early treatment. The other generated evidence and included investigations were then grouped together and are the subject of this publication. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-05-15 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/158016 10.6061/clinics/2019/e722 |
url |
https://www.revistas.usp.br/clinics/article/view/158016 |
identifier_str_mv |
10.6061/clinics/2019/e722 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/158016/153260 https://www.revistas.usp.br/clinics/article/view/158016/153564 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2019 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2019 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/xml |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 74 (2019); e722 Clinics; v. 74 (2019); e722 Clinics; Vol. 74 (2019); e722 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222764156583936 |